Cargando…

Association between malaria exposure and Kaposi's sarcoma-associated herpes virus seropositivity in Uganda

OBJECTIVE: Unlike other herpes viruses, Kaposi's sarcoma-associated herpes virus (KSHV) is not ubiquitous worldwide and is most prevalent in sub-Saharan Africa. The reasons for this are unclear. As part of a wider investigation of factors that facilitate transmission in Uganda, a high prevalenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nalwoga, Angela, Cose, Stephen, Wakeham, Katie, Miley, Wendell, Ndibazza, Juliet, Drakeley, Christopher, Elliott, Alison, Whitby, Denise, Newton, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2015
Materias:	Original Research Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4390463/ https://www.ncbi.nlm.nih.gov/pubmed/25611008 http://dx.doi.org/10.1111/tmi.12464

Ejemplares similares

Risk Factors for Seropositivity to Kaposi Sarcoma–Associated Herpesvirus Among Children in Uganda
por: Wakeham, Katie, et al.
Publicado: (2013)

Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women
por: Wakeham, Katie, et al.
Publicado: (2011)

Trends in Kaposi's sarcoma-associated Herpesvirus antibodies prior to the development of HIV-associated Kaposi's sarcoma: A nested case-control study
por: Wakeham, Katie, et al.
Publicado: (2015)

Kaposi’s sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands
por: Nalwoga, Angela, et al.
Publicado: (2019)

Kaposi’s sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda
por: Nalwoga, Angela, et al.
Publicado: (2021)

Comparison of Epstein-Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3 to 89 years from Uganda
por: Nalwoga, Angela, et al.
Publicado: (2023)

Comparison of Epstein–Barr virus and Kaposi’s sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3–89 years from Uganda
por: Nalwoga, Angela, et al.
Publicado: (2023)

Variation in KSHV prevalence between geographically proximate locations in Uganda
por: Nalwoga, Angela, et al.
Publicado: (2020)

Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi’s Sarcoma development
por: Dai, Lu, et al.
Publicado: (2018)

Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa
por: Malope-Kgokong, Babatyi I, et al.
Publicado: (2010)

Malaria during pregnancy and transplacental transfer of Kaposi sarcoma-associated herpesvirus (KSHV) antibodies: a cohort study of Kenyan mother and child pairs
por: Sabourin, Katherine R., et al.
Publicado: (2020)

Prevalence and predictors of kaposi sarcoma herpes virus seropositivity: a cross-sectional analysis of HIV-infected adults initiating ART in Johannesburg, South Africa
por: Maskew, Mhairi, et al.
Publicado: (2011)

High Seroprevalence of Kaposi Sarcoma–Associated Herpesvirus in Men Who Have Sex With Men With HIV in the Southern United States
por: Knights, Sheena M, et al.
Publicado: (2023)

Epstein–Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992–2008
por: Sabourin, Katherine R., et al.
Publicado: (2023)

A population-based study of Kaposi Sarcoma-associated herpesvirus seropositivity in Uganda using principal components analysis
por: Chang, Joanne T, et al.
Publicado: (2013)

Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda
por: Newton, R, et al.
Publicado: (2003)

Oral Kaposi's sarcoma: Sole presentation in HIV seropositive patient
por: Arul, A. Sri Kennath J., et al.
Publicado: (2015)

Further experience with Kaposi's sarcoma in Uganda.
por: Serwadda, D., et al.
Publicado: (1986)

Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma
por: Dedicoat, M, et al.
Publicado: (2003)

Kaposi sarcoma herpesvirus viral load as a biomarker for leptomeningeal involvement by primary effusion lymphoma
por: Lurain, Kathryn, et al.
Publicado: (2022)

Genome-Wide Sequence Analysis of Kaposi Sarcoma-Associated Herpesvirus Shows Diversification Driven by Recombination
por: Sallah, Neneh, et al.
Publicado: (2018)

The prognostic significance of facial lymphoedema in HIV-seropositive subjects with Kaposi sarcoma
por: Feller, L, et al.
Publicado: (2008)

Kaposi's Sarcoma in Uganda: Geographic and Ethnic Distribution
por: Taylor, J. F., et al.
Publicado: (1972)

Activation of DNA Damage Response Induced by the Kaposi’s Sarcoma-Associated Herpes Virus
por: Di Domenico, Enea Gino, et al.
Publicado: (2016)

Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
por: Uldrick, Thomas, et al.
Publicado: (2010)

Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma
por: Tudor, S, et al.
Publicado: (2014)

Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia
por: Singh, Rajnish Kumar, et al.
Publicado: (2018)

Misdiagnosis of Human Herpes Virus-8-Associated Kaposi's Sarcoma as Adverse Drug Eruptions
por: Kim, Tae Hyung, et al.
Publicado: (2022)

Immunization of Mice with Virus-Like Vesicles of Kaposi Sarcoma-Associated Herpesvirus Reveals a Role for Antibodies Targeting ORF4 in Activating Complement-Mediated Neutralization
por: Lam, Alex K., et al.
Publicado: (2023)

Antibodies against lytic and latent Kaposi's sarcoma-associated herpes virus antigens and lymphoma in the European EpiLymph case–control study
por: Benavente, Y, et al.
Publicado: (2011)

Kaposi Sarcoma Herpes Virus-associated Hemophagocytic Syndrome Complicated by Multicentric Castleman Disease and Kaposi Sarcoma in a HIV-negative Immunocompetent Patient: An Autopsy Case
por: Kim, Bomi, et al.
Publicado: (2009)

A Kaposi’s sarcoma-associated herpes virus-encoded microRNA contributes to dilated cardiomyopathy
por: Zhao, Yanru, et al.
Publicado: (2023)

Kaposi's sarcoma-associated herpesvirus polyadenylated nuclear RNA: a structural scaffold for nuclear, cytoplasmic and viral proteins
por: Sztuba-Solinska, Joanna, et al.
Publicado: (2017)

[(18)F]-fluoro-D-deoxyglucose positron emission tomography findings in Kaposi sarcoma herpes virus associated multicentric Castleman disease: correlation with clinical, inflammatory, and virologic parameters
por: Polizzotto, Mark N, et al.
Publicado: (2012)

Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA
por: Gruffaz, Marion, et al.
Publicado: (2020)

Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues
por: Sun, Rui, et al.
Publicado: (2017)

Kaposi’s Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi’s Sarcoma
por: Jary, Aude, et al.
Publicado: (2021)

Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide
por: Davis, David A., et al.
Publicado: (2017)

Structural Insight into KsBcl-2 Mediated Apoptosis Inhibition by Kaposi Sarcoma Associated Herpes Virus
por: Suraweera, Chathura D., et al.
Publicado: (2022)

AIDS-associated Kaposi sarcoma in Uganda: response to treatment with highly active antiretroviral therapy and chemotherapy
por: Nguyen, HQ, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_fj6hq794sbshoj9pj4qkal1kgm